Back to Search
Start Over
Supplemental Table 3 from Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental table 3. Nanostring nCounter Differential gene expression (excel file) -uploading separately.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....37333463950a2210ccb3a2b1284f1edc
- Full Text :
- https://doi.org/10.1158/1078-0432.22472351